Literature DB >> 30911630

Preserving fertility in pseudomyxoma peritonei, a novel approach.

Lisa A Sheehan1, Akash M Mehta1, Saladin Sawan2, Sanjeev P Dayal1, Faheez Mohamed1, Brendan J Moran1, Tom D Cecil1.   

Abstract

BACKGROUND: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the gold standard treatment for patients with pseudomyxoma peritonei (PMP) but involves routine bilateral salpingo-oophorectomy. Young women wishing to maintain fertility may be reluctant to pursue this. An alternative strategy in women with low-grade PMP has been explored in the form of laparoscopic evacuation of pelvic and ovarian mucin with resection of the appendiceal tumour.
METHODS: Between January 2012 and January 2015, four young women (aged 28-35 years) with PMP seeking to maintain fertility underwent laparoscopy, appendicectomy and pelvic mucinous evacuation and washout. Data regarding intra-operative and histopathological findings were collected. Endpoints were fertility-related outcomes and oncological follow-up.
RESULTS: Infertility was a presenting symptom in three of the four women. All four had significant pelvic mucinous disease on radiological imaging and were offered CRS and HIPEC as definitive treatment, but chose laparoscopy with appendicectomy and copious irrigation and washout of the pelvis with stripping of mucinous disease off the ovarian surfaces. Postoperative histology demonstrated a low-grade appendiceal mucinous neoplasm (LAMN) in all patients with acellular mucin or low-grade mucinous carcinoma peritonei in the peritoneal cavity. All patients successfully conceived subsequently and gave birth to healthy babies. After 12-29 months follow-up, all women are well with no radiological or laparoscopic evidence of disease recurrence.
CONCLUSIONS: In patients with low-grade PMP, initial therapeutic laparoscopy can restore fertility, whilst providing short- to medium-term disease control. This modality in young women wishing to have children appears to be a feasible alternative to immediate CRS and HIPEC.

Entities:  

Keywords:  infertility; pseudomyxoma peritonei; therapeutic laparoscopy

Year:  2017        PMID: 30911630      PMCID: PMC6386434          DOI: 10.1515/pp-2016-0024

Source DB:  PubMed          Journal:  Pleura Peritoneum        ISSN: 2364-768X


  16 in total

1.  Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  S van Ruth; A A M Hart; J M G Bonfrer; V J Verwaal; F A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Dario Baratti; Shigeki Kusamura; Antonia Martinetti; Ettore Seregni; Barbara Laterza; Daniela G Oliva; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2007-05-18       Impact factor: 5.344

3.  Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.

Authors:  D J Evers; V J Verwaal
Journal:  Br J Surg       Date:  2011-02       Impact factor: 6.939

4.  A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.

Authors:  Dominique Elias; Emilie Duchalais; Peggy Dartigues; Pierre Duvillard; Catherine Poirot; Diane Goéré
Journal:  Ann Surg Oncol       Date:  2013-02-01       Impact factor: 5.344

5.  Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence.

Authors:  F Alexander-Sefre; K Chandrakumaran; S Banerjee; R Sexton; J M Thomas; B Moran
Journal:  Colorectal Dis       Date:  2005-07       Impact factor: 3.788

6.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination.

Authors:  Paul H Sugarbaker
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?

Authors:  D Elias; E Duchalais; A David; P Dartigues; P Duvillard; C Poirot; D Goéré
Journal:  Eur J Surg Oncol       Date:  2013-03-21       Impact factor: 4.424

Review 8.  The etiology, clinical presentation, and management of pseudomyxoma peritonei.

Authors:  Brendan J Moran; Thomas D Cecil
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

9.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

Review 10.  Surgical techniques in visceral resection and peritonectomy procedures.

Authors:  Philip Bao; David Bartlett
Journal:  Cancer J       Date:  2009 May-Jun       Impact factor: 3.360

View more
  2 in total

1.  Laparoscopic cytoreductive surgery and HIPEC in LAMN with small volume of peritoneal disease: a valuable option of treatment for good patient-related experience measures (PREMs).

Authors:  Caterina Cusumano; Sébastien Carrere; Alix Bouillin; Stéphanie Nougaret; Lakhdar Khellaf; François Quénet; Olivia Sgarbura
Journal:  Surg Endosc       Date:  2021-11-29       Impact factor: 3.453

2.  Prognosis for Young Females with Pseudomyxoma Peritonei of Appendiceal Origin and Unilateral or Bilateral Ovaries Preserved During Cytoreductive Surgery.

Authors:  Fengxian Fu; Huangdong Tang; Yiyan Lu; Dongmei Lu; Ruiqing Ma
Journal:  Front Surg       Date:  2022-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.